Dr. Borros Michael Arneth is a medical researcher specializing in clinical chemistry, laboratory medicine, molecular diagnostics, and pathobiochemistry. His academic foundation was established at the Johann Wolfgang Goethe University in Frankfurt am Main, where he studied biochemistry and human medicine. His doctoral research focused on magnetic resonance spectroscopic investigations of fatty acid-binding proteins (FABP) in HIV patients, contributing to the understanding of biochemical alterations in neurodegenerative and infectious diseases. Over his career, Dr. Arneth has served as a research assistant and later as a senior physician at leading institutions, including the Carl Gustav Carus University Hospital in Dresden and the University Hospital Mainz. His expertise extends to areas such as clinical biochemistry, immunology, and medical microbiology. He has achieved recognition as a European Specialist in Clinical Chemistry and Laboratory Medicine (EurClinChem) and has been actively involved in scientific publishing as an editor and reviewer for multiple international journals, including Clinical Biochemistry and the International Journal of Immunology. His research emphasizes biochemical mechanisms underlying disease processes, molecular diagnostics, and advancements in laboratory medicine for clinical applications.
Featured Publications:
Arneth, B., Arneth, R., & Shams, M. (2019). Metabolomics of type 1 and type 2 diabetes. International Journal of Molecular Sciences, 20(10), 2467.
Shams, M. E. E., Arneth, B., Hiemke, C., Dragicevic, A., Müller, M. J., Kaiser, R., & others. (2006). CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. Journal of Clinical Pharmacy and Therapeutics, 31(5), 493–502.
Arneth, B. (2018). Update on the types and usage of liquid biopsies in the clinical setting: A systematic review. BMC Cancer, 18(1), 527.
Arneth, B. M. (2019). Impact of B cells to the pathophysiology of multiple sclerosis. Journal of Neuroinflammation, 16(1), 128.